CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-02 | Izzar Rachid Head of Alzheimer's Disease | Option exercise · Restricted Stock Unit | −425 | 433 | ||
| 2022-12-02 | Izzar Rachid Head of Alzheimer's Disease | Other disposition · Restricted Stock Unit | −433 | 0 | ||
| 2022-12-02 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +131 | 2,807.29 | ||
| 2022-12-02 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −39 | $298.90 | $12K | 2,768.29 |
| 2022-12-02 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise · Restricted Stock Unit | −131 | 0 | ||
| 2022-12-01 | Viehbacher Christopher President and CEO | Grant or award · Stock Option | +80,522 | 80,522 | ||
| 2022-12-01 | Viehbacher Christopher President and CEO | Grant or award · Restricted Stock Unit | +7,040 | 7,040 | ||
| 2022-12-01 | Viehbacher Christopher President and CEO | Grant or award · Performance Stock Unit | +45,998 | 45,998 | ||
| 2022-11-14 | Gregory Ginger EVP, Human Resources | Sale | −5,610 | $300.11 | $1.7M | 5,711.02 |
| 2022-10-27 | ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec | Sale | −5,532 | $280.70 | $1.6M | 39,396 |
| 2022-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise | +2,682 | 7,109 | ||
| 2022-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Shares withheld for taxes | −1,372 | $199.79 | $274K | 5,737 |
| 2022-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise | +2,064 | 7,801 | ||
| 2022-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Shares withheld for taxes | −1,056 | $199.79 | $211K | 6,745 |
| 2022-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,682 | 2,682 | ||
| 2022-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Option exercise · Restricted Stock Unit | −2,064 | 8,664 | ||
| 2022-09-01 | MCDONNELL MICHAEL R EVP, Chief Financial Officer | Other disposition · Restricted Stock Unit | −3,298 | 5,366 | ||
| 2022-08-01 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +255 | 2,170.29 | ||
| 2022-08-01 | Murphy Nicole Head of Pharm Ops and Tech | Shares withheld for taxes | −76 | $209.26 | $16K | 2,094.29 |
| 2022-08-01 | Murphy Nicole Head of Pharm Ops and Tech | Option exercise | +825 | 2,919.29 |
Page 27 of 29 · 579 trades